Clinical Trials Browser

N-dihydrogalactochitosan × Dermatologic × 90 days × Clear all

NCT03993678 2025-12-30

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.

Phase 1/2 Completed

DermatologicSarcoma

Melanoma, Sarcoma